Eqis Capital Management Inc. cut its stake in Integer Holdings Corp (NYSE:ITGR) by 12.2% during the fourth quarter, Holdings Channel reports. The fund owned 9,881 shares of the medical equipment provider’s stock after selling 1,379 shares during the quarter. Eqis Capital Management Inc.’s holdings in Integer were worth $754,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of ITGR. FMR LLC bought a new stake in Integer in the third quarter worth $36,552,000. BlackRock Inc. boosted its holdings in Integer by 8.0% during the third quarter. BlackRock Inc. now owns 4,768,207 shares of the medical equipment provider’s stock valued at $395,523,000 after acquiring an additional 352,525 shares during the period. Matarin Capital Management LLC bought a new stake in Integer during the third quarter valued at about $20,709,000. Castleark Management LLC bought a new stake in Integer during the third quarter valued at about $15,613,000. Finally, Renaissance Technologies LLC boosted its holdings in Integer by 199.4% during the third quarter. Renaissance Technologies LLC now owns 235,300 shares of the medical equipment provider’s stock valued at $19,518,000 after acquiring an additional 156,700 shares during the period. Hedge funds and other institutional investors own 96.04% of the company’s stock.

ITGR stock opened at $77.71 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.41 and a quick ratio of 1.32. Integer Holdings Corp has a 52-week low of $42.50 and a 52-week high of $90.03. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of 27.65 and a beta of 1.00.

Integer (NYSE:ITGR) last released its earnings results on Thursday, November 1st. The medical equipment provider reported $1.06 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.92 by $0.14. Integer had a net margin of 14.12% and a return on equity of 12.78%. The business had revenue of $305.10 million during the quarter, compared to analysts’ expectations of $301.95 million. During the same quarter last year, the company earned $0.91 earnings per share. The firm’s revenue was up 6.6% on a year-over-year basis. As a group, equities analysts anticipate that Integer Holdings Corp will post 3.66 EPS for the current fiscal year.

In related news, Director Pamela G. Bailey sold 5,767 shares of the stock in a transaction dated Tuesday, November 20th. The shares were sold at an average price of $83.16, for a total value of $479,583.72. Following the completion of the sale, the director now owns 53,562 shares in the company, valued at $4,454,215.92. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Joseph F. Flanagan sold 13,633 shares of the stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $86.42, for a total transaction of $1,178,163.86. Following the completion of the sale, the executive vice president now owns 12,622 shares of the company’s stock, valued at approximately $1,090,793.24. The disclosure for this sale can be found here. In the last quarter, insiders sold 30,569 shares of company stock valued at $2,653,687. 3.60% of the stock is owned by corporate insiders.

A number of equities research analysts have issued reports on the stock. TheStreet cut shares of Integer from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Royal Bank of Canada upped their price target on shares of Integer to $84.00 in a report on Friday, November 2nd. KeyCorp upped their price target on shares of Integer from $81.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, November 2nd. Finally, Zacks Investment Research cut shares of Integer from a “strong-buy” rating to a “hold” rating in a report on Monday, January 7th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Integer currently has an average rating of “Buy” and an average target price of $85.80.

ILLEGAL ACTIVITY NOTICE: “Eqis Capital Management Inc. Reduces Stake in Integer Holdings Corp (ITGR)” was first published by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.dailypolitical.com/2019/01/30/eqis-capital-management-inc-reduces-stake-in-integer-holdings-corp-itgr.html.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.

Featured Story: Can individual investors take part in an IPO?

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.